ForDyne B.V. files Form 144 showing April 2026 share sales

ForDyne B.V. submitted a Form 144 notice reporting proposed sales of Common Stock on multiple dates in April 2026.

Rhea-AI Filing Summary

ForDyne B.V. submitted a Form 144 notice reporting proposed sales of Common Stock on multiple dates in April 2026. The filing lists specific lots sold: 04/15/2026 (92,956 shares, $1,893,634.56), 04/16/2026 (6,657 shares, $133,522.78), 04/17/2026 (211,974 shares, $4,301,291.62), 04/20/2026 (125,274 shares, $2,513,898.41), 04/21/2026 (8,300 shares, $166,120.35), and 04/22/2026 (2,652 shares, $53,049.28). The Form references an IPO Conversion of Shares dated 09/17/2020 and lists UBS Financial Services as a broker on Nasdaq.

Insights

Securities Counsel

Form 144 lists scheduled/resorted resale transactions by an affiliate over several April 2026 dates.

The filing provides itemized sale lots with share counts and gross proceeds for each date, consistent with a Rule 144 resale notice. It also cites an IPO Conversion of Shares dated 09/17/2020, which may describe the origin of the shares.

Timing and final cash‑flow treatment are not detailed beyond the per‑lot amounts; subsequent Form 4s or trade reports would clarify actual dispositions and net proceeds after commissions or withholding.

Key Figures

04/17/2026 lot: 211,974 shares 04/17/2026 proceeds: $4,301,291.62 04/20/2026 lot: 125,274 shares +4 more

7 metrics

04/17/2026 lot 211,974 shares reported sale lot on <date>04/17/2026</date>

04/17/2026 proceeds $4,301,291.62 gross proceeds listed for the 04/17/2026 lot

04/20/2026 lot 125,274 shares reported sale lot on <date>04/20/2026</date>

04/20/2026 proceeds $2,513,898.41 gross proceeds listed for the 04/20/2026 lot

04/15/2026 lot 92,956 shares reported sale lot on <date>04/15/2026</date>

04/15/2026 proceeds $1,893,634.56 gross proceeds listed for the 04/15/2026 lot

IPO Conversion of Shares 09/17/2020 origin date for the securities listed as 'IPO Conversion of Shares'

Key Terms

Form 144, IPO Conversion of Shares, gross proceeds

3 terms

Form 144 regulatory

"submitted a Form 144 notice reporting proposed sales of Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

IPO Conversion of Shares market

"The filing references an IPO Conversion of Shares dated 09/17/2020"

gross proceeds financial

"lists per‑lot share counts and gross proceeds for each date"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ForDyne B.V.'s Form 144 filing for DYN report?

The filing reports proposed sales of Common Stock on several April 2026 dates. It lists per‑lot share counts and gross proceeds, for example 211,974 shares for $4,301,291.62 on 04/17/2026. The notice documents resale activity under Rule 144.

Which broker and market are referenced in the Form 144 for DYN?

The filing names UBS Financial Services Inc. at 11 Madison Avenue and lists Nasdaq as the market. The broker and exchange are noted in the securities information fields of the Form 144 notice.

What are the largest reported lots and proceeds in the April 2026 entries?

The largest listed lot is 211,974 shares on 04/17/2026 with gross proceeds of $4,301,291.62. Other sizeable lots include 125,274 shares ($2,513,898.41) on 04/20/2026 and 92,956 shares ($1,893,634.56) on 04/15/2026.

Does the Form 144 specify whether the issuer receives proceeds from these sales?

The notice lists gross proceeds per lot but does not state the recipient of proceeds explicitly. Form 144 typically reports proposed resale by holders; the filing does not assign proceeds to the issuer in the provided excerpt.

What does the reference to 'IPO Conversion of Shares' dated 09/17/2020 mean here?

The form notes an IPO Conversion of Shares on 09/17/2020 as the securities' origin. This phrase identifies how the reported shares were originally obtained but the excerpt does not expand on conversion mechanics or related terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/17/2026 - 04:03 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002019392
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Dyne Therapeutics, Inc.
SEC File Number	001-39509
Address of Issuer	1560 TRAPELO ROAD WALTHAM MASSACHUSETTS 02451
Phone	(781) 786-8230
Name of Person for Whose Account the Securities are To Be Sold	ForDyne B.V.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	348317	6384650.61	165313796	06/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2020	IPO Conversion of Shares	Issuer			348317	09/17/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ForDyne B.V 1560 TRAPELO ROAD Waltham MA 02451	Common	04/15/2026	92956	1893634.56
ForDyne B.V. 1560 TRAPELO ROAD Waltham MA 02451	Common	04/16/2026	6657	133522.78
ForDyne B.V. 1560 TRAPELO ROAD Waltham MA 02451	Common	04/17/2026	211974	4301291.62
ForDyne B.V. 1560 TRAPELO ROAD Waltham MA 02451	Common	04/20/2026	125274	2513898.41
ForDyne B.V. 1560 TRAPELO ROAD Waltham MA 02451	Common	04/21/2026	8300	166120.35
ForDyne B.V. 1560 TRAPELO ROAD Waltham MA 02451	Common	04/22/2026	2652	53049.28

144: Remarks and Signature

Remarks
Date of Notice	06/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for ForDyne B.V.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)